Netherlands · 
What does Gilde Healthcare invest in?
Gilde Healthcare invests most often at Series B and Series C (56% of the rounds on record), in sectors such as Connected-health, Wellbeing and Healthtech.
Gilde Healthcare highlights
- 01
3 cheques in the last 12 months
- 02
Mostly Series B and Series C: 56% of its rounds
- 03
Sole investor in 8 rounds, median $11M
- 04
10 exits from the portfolio
What they do
Gilde Healthcare is a specialized healthcare investor managing over €3 billion across three fund strategies: Venture&Growth in healthcare, Private Equity in healthcare and Climate Solutions.From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- Connected-healthWellbeingHealthtech
- Based in
- Utrecht, Netherlands
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first56 appearances
- 2026
3 rounds
- Jun
- Apr
- Feb
- 2025
1 round
- Jan
- 2019
4 rounds
- Jul
- May
- Feb
- Jan
- 2018
1 round
- May
- 2017
2 rounds
- Jul
- Mar
- 2015
3 rounds
- Sept
- Jun
- May
- 2014
6 rounds
- Nov
- Oct
- Sept
- Apr
- Mar
- Jan
- 2013
1 round
- Nov
- 2012
7 rounds
- Dec
- Oct
- Sept
- Jun
- May
- May
- Jan
- 2011
5 rounds
- Nov
- Aug
- Jul
- Mar
- Feb
- 2010
2 rounds
- Nov
- Oct
- 2009
3 rounds
- Oct
- Sept
- Aug
- 2008
2 rounds
- Jul
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration5 named
DBDirkjan BeugelsdijkCFO; Director CiForm ADV
EDEdwin De GraafManaging Partner, Director aiForm ADV
JVJasper Van GorpManaging Partner, Director BiForm ADV
LSLudo SuijkerbuijkChief Compliance OfficeriForm ADV
PVPieter Van Der MeerManaging Partner, Director aiForm ADV
We also hold 34 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$2.4Bgross assets of its fundsOct 2026
5+funds on filenumbered funds in its name
Exemptreporting adviserventure or small private funds
- Legal name
- Gilde Healthcare Partners B.v.
- SEC number
- CRD 163373
Exits from the portfolio
Companies it backed that were later bought or listed10 in all
ProsonixBought by CircassiaUndisclosedMay 2015
DefiniensBought by MedImmune$150MNov 2014
Santaris PharmaBought by Roche$450MAug 2014
ProFibrixBought by The Medicines Company$240MAug 2013
Conatus PharmaceuticalsListed$69MJun 2013
MTM LaboratoriesBought by RocheUndisclosedJul 2011
FlowCardiaBought by C. R. BardUndisclosedMay 2010
AblynxListedUndisclosedNov 2007
Glycart Biotechnology AGBought by RocheUndisclosedJul 2005
An exit counts when it came after the firm's first round in the company. From historical deal records.